Gonzalo Marc-Perez

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial: Correction.

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial: Correction.

Journal: Obstetrics and gynecology

Published: July 16, 2026

More evidence needed for maternal RSVpreF protection to age 6 months - Authors' reply.

More evidence needed for maternal RSVpreF protection to age 6 months - Authors' reply.

Journal: The Lancet. Infectious diseases

Published: June 06, 2025

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine: Correction.

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine: Correction.

Journal: Obstetrics and gynecology

Published: May 15, 2025

Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control study.

Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control study.

Journal: The Lancet. Infectious diseases

Published: December 13, 2024

Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial.

Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial.

Journal: Vaccine

Published: November 15, 2024

RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.

RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.

Journal: The New England journal of medicine

Published: October 16, 2024

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine.

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine.

Journal: Obstetrics and gynecology

Published: September 18, 2024

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial.

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial.

Journal: Obstetrics and gynecology

Published: September 17, 2024

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.

Journal: The Journal of infectious diseases

Published: February 07, 2024

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.

Journal: The New England journal of medicine

Published: December 13, 2023

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

Journal: The New England journal of medicine

Published: April 05, 2023

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.

Journal: The New England journal of medicine

Published: May 04, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026